DANTE PAZZANESE INSTITUTE OF CARDIOLOGY, SÃO PAULO, BRAZIL

Slides:



Advertisements
Similar presentations
Ionotropic Therapy in Acute Heart Failure
Advertisements

SMASH-VT Trial Presented at The Heart Rhythm Society Meeting May 2006 Presented by Dr. Vivek Reddy Substrate Mapping and Ablation in Sinus Rhythm to Halt.
Arrhythmias: The Good, the Bad and the Ugly
ICD FOR PRIMARY PREVENTION EVIDENCE REVIEW
Ventricular Tachyarrhythmias
Cardiomyopathy. Cardiomyopathy, which literally means "heart muscle disease", is the deterioration of the function of the myocardium (i.e., the actual.
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
Mr. J is a 70 year old man with an ischemic cardiomyopathy who presents with class III CHF and significant dissatisfaction with his functional capacity.
Beta Blockade and the Heart John Hakim, M.D Cardiology Fellow West Virginia University Division of Cardiology.
Amiodarone Use in Cardiac Surgical Resuscitation
Atrial Fibrillation Dr Nidhi Bhargava 8/10/13.
Atrial Fibrillation Andreas Stein Robert Smith, M.D. August 11, 2003.
Indication and contra-indications for cardiac catheterization
Ventriclar Tachycardia
Safety and feasibility of dobutamine stress cardiac magnetic resonance for cardiovascular assessment prior to renal transplantation Ripley DP 1,2, Gosling.
Ablation: past, present, and future Dr Eric Prystowsky Director Clinical Electrophysiology Laboratory St Vincent Hospital Indianapolis Dr Mel Scheinman.
Device and Antiarrhythmic Drugs: Advantages and Pitfalls Teresa Menendez Hood, M.D.
Endovascular treatment on tandem lesions of cranial arteries Xiao-Long Zhang, MD, PhD Department of Radiology Huashan Hospital,Fudan University Shanghai.
Update of 2013 ACCF/AHA Guidelines for STEMI Junbo Ge MD,FACC,FESC,FSCAI Zhongshan Hospital, Fudan University.
Introduction Most patients undergoing left ventricular assist device (LVAD) implantation for destination therapy (DT) also have an implantable cardioverter.
The Electrical Management of Cardiac Rhythm Disorders Tachycardia Indications for ICD Implantation.
INTRODUCTION: INTRODUCTION: implantable cardioverter-defibrillators (ICDs) have clearly demonstrated to terminate an elevated percentage of sustained ventricular.
An ICD for every CRT patient ?
The Case for Rate Control: In the Management of Atrial Fibrillation Charles W. Clogston, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April.
THE HEART’S ELECTRICAL SYSTEM Marco Perez, MD Center for Inherited Cardiovascular Disease Inherited Cardiac Arrhythmia Clinic June 20, 2013.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Multicenter Outcomes for Catheter Ablation of Idiopathic.
Fotlos Laspas'. Evangelia Sotiropoitlou'. Sophia Myhna^. Anita Manataki', Paraskevi TsagouW. Iris Tsangaridou', Loukas Thanos'
Radiofrequency Ablation as Initial Therapy in Paroxysmal Atrial Fibrillation Jens Cosedis Nielsen, M.D., D.M.Sc., Arne Johannessen, M.D., D.M.Sc., Pekka.
Journal of the American College of Cardiology Vol. 61, No. 4, 2013 Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation.
With 2 : 1 conduction, the ventricular rate is approximately 150 beats/min, often making flutter waves themselves difficult to appreciate and allowing.
Cardiac Catheterization Complication
Ethical Scenario: Cardiovascular System
Revascularization of the Heart
Wearable Cardioverter Defibrillators
Zoll Firm Lecture Series
Cardiovascular system
HESS 509 Atrial Fibrillation CHAPTER ELEVEN
Total Occlusion Study of Canada (TOSCA-2) Trial
Review of the Toxicology Investigators Consortium (ToxIC)
Sudden Cardiac Arrest Morhaf Ibrahim, MD, FHRS Electrophysiology.
University of Ottawa Heart Institute and Turku PET Centre
These slides highlight a presentation at the Late Breaking Trial Session of the American College of Cardiology 52nd Annual Scientific Sessions in Chicago,
Fontan Global Case Conference Richard J. Czosek, MD 6/28/17
Multi Modality Approach to Diagnosis of Ischemia in Post CABG Cases
Right ventricular disarticulation for arrythmogenic right ventricular dysplasia: an 18 year single centre experience. J Zacharias, J Forty, C Doig*, J.
Obstructive Hypertrophic Cardiomyopathy
OneShot™ Renal Denervation System
RevElution Clinical Trial
Acromegaly is characterized by excessive growth hormone (GH) secretion and is primarily caused by a GH-secreting pituitary adenoma, which stimulates.
Atrial Fibrillation: When Should You Consider Ablation?
Simon A. Castro, MD; Daniele Muser, MD; Erica Zado, PA; Rajeev K
Is There a Need to Address AF in patients Undergoing Valve Surgery?
American College of Cardiology Presented by Dr. Stuart J. Connolly
57 (27%) limited or no EPI RFA 9 persistent bleeding after access
Poongkodi Nagappan and Supul Hennayake
A randomized controlled trial of distal renal denervation vs conventional mode of the intervention for treatment of resistant hypertension Stanislav Pekarskiy.
Treatment With Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART) For Non-Small Cell Lung Cancer (NSCLC): The Weston Park Hospital Experience.
Mapping Sympathetic Nerve Distribution for
Evaluating Sepsis Guidelines and Patient Outcomes
In the name of God.
THE NEED OF SCREENING OF ASYMPTOMATIC PATIENTS RESULTS
ATHENA Trial Presented at Heart Rhythm 2008 in San Francisco, USA
HYPERTROPHIC CARDIOMYOPATHY(HCM)
The most common cause of death in North America is cardiac death and the most common cause of cardiac death is sudden death from ventricular arrhythmias.
ΝΟΣΟΣ ΤΑΧΥΒΡΑΔΥΚΑΡΔΙΑΣ: ΕΜΦΥΤΕΥΣΗ ΒΗΜΑΤΟΔΟΤΗ Η ΚΑΤΑΛΥΣΗ ΚΟΛΠΙΚΗΣ ΜΑΡΜΑΡΥΓΗΣ ; ΓΕΩΡΓΙΟΣ ΣΤΑΥΡΟΠΟΥΛΟΣ ΕΠ.Α ΚΑΡΔΙΟΛΟΓΟΣ ΓΝΘ ΙΠΠΟΚΡΑΤΕΙΟ.
Pediatric Cardiology Emergencies
FDA Perspective Marco Cannella, PhD Senior Lead Reviewer
The Heart Rhythm Society Meeting Presented by Dr. Johan De Sutter
Case 1: A 78-year-old white female with hypertension and hyperlipidemia Discussion Points: In that this patient has documented atherosclerotic vascular.
Khalid AlHabib Professor of Cardiac Sciences Cardiology Consultant
Presentation transcript:

DANTE PAZZANESE INSTITUTE OF CARDIOLOGY, SÃO PAULO, BRAZIL Renal sympathetic denervation: new treatment for the electrical storm in patients with ICD. D.Moreira, L.V Armaganijan, R. Staico, R.G Habib, P.T.J Medeiros, A. Abizaid DANTE PAZZANESE INSTITUTE OF CARDIOLOGY, SÃO PAULO, BRAZIL INTRODUCTION Electrical storm is a catastrophic event that affects patients (P) with severe cardiomyopathy and is not a rare complication in P with ICD. The causes are multifactorial. Adrenergic hyperactivity plays an important role in the initiation and maintenance of ventricular arrhythmias (VA). Treatment of this severe condition may include radiofrequency ablation, complete sedation and sometimes intraaortic baloon counterpulsation. The results, however are not always encouraging and other approaches may be necessary. Renal sympathetic denervation (RSD) has been demonstrated to decrease the adrenergic influence on cardiovascular system and it has been used for the treatment of P with refractory hypertension. There are anecdotal reports showing benefits of this procedure for the treatment of P with electrical storm. Objective: To evaluate the effects of RSD in P with ICD hospitalized with electrical storm METHODS We included in this series 10P (mean age 64±6 years; 6P with Chagas disease, 2P with dilated idiopathic cardiomyopathy and 2P with ischemic cardiomyopathy, mean EF 31.7±11 %) admitted with at least three episodes of VT/VF (ranging from 8 to 106 episodes) requiring shocks or repeated ATP therapies within 24h. All P were considered refractory to antiarrhythmic therapy, including maximum tolerated dose of amiodarone, lidocaine, magnesium sulfate and beta- blocker and were not candidates for ablation of the arrhythmogenic focus (3P had intracavitary thrombus; 5P polymorphic VT, and 2P had prior failed ablation). After clinical stabilization, all P underwent RSD. Radiofrequency energy was applied to both renal arteries, starting from the distal portion towards the proximal portion with a distance of at least 0.5 cm between each lesion by means of irrigated tip catheter. Mean procedure time was 30 min. RESULTS All P tolerated the procedure well without complications. The mean number of lesions was 5.5±3.4/artery/P. After the prodeure two P had VT within the first week after RSD and were successfully treated by 5J internal shock with no VA recurrence. One P had accelerated idioventricular rhythm one week later which was successfully treated by RF ablation. In one P, RSD was unsuccesfull (multiple renal arteries) and was submitted to RF ablation thirty days later. Three patients died 18 days and 30 days due to refractory congestive heart failure and, 75 days after RSD due to sepsis . No more episodes of sustained VA were seen during the follow-up (mean of 6.3±3 mo, ranging from 2 mo to 15 mo). The median number of VT/ATP/shocks decreased from 28.5/20.5/8 to 1/0/0 at 1 mo and 6 mo after RSD, respectively (p<0,001). CONCLUSIONS a) RSD is an effective and safe technique for the treatment of electrical storm b) RSD may be indicated in P when other forms of nonpharmacological treatments are contraindicated or ineffective; c) larger sample size and longer follow-up are needed to confirm our results.